Mebeverine Extended Release Pellets-Suitable for filling in 135mg & 200mg Capsules.

  • MKPPL achieved the desired sustained release profile equivalent to innovator
  • Mebeverine is an antispasmodic medicine which is taken to relieve bloating and cramp pain in the lower abdomen. These symptoms are commonly associated with the gastrointestinal condition called irritable bowel syndrome.
  • MKPPL aims to deliver Mebeverine as an inhibitor of calcium-depot replenishment. Musculotropic compounds act directly on the gut muscles at the cellular level to relax them. This relieves painful muscle spasms of the gut without affecting its normal motility.
  • Offer complete technical package for registrations in all regulated/semi regulated markets.

Additional information

60%, 80%

Release Type

Extended Release

Target Formulations


Documentation Available:

Technical Package

Privacy Preference Center